CSIMarket
 
Tandem Diabetes Care Inc   (TNDM)
Other Ticker:  
 
 
Price: $28.6200 $0.62 2.214%
Day's High: $28.7 Week Perf: -3.11 %
Day's Low: $ 27.84 30 Day Perf: 16.58 %
Volume (M): 1,239 52 Wk High: $ 44.05
Volume (M$): $ 35,460 52 Wk Avg: $27.14
Open: $28.42 52 Wk Low: $13.82



 Market Capitalization (Millions $) 1,857
 Shares Outstanding (Millions) 65
 Employees 1,630
 Revenues (TTM) (Millions $) 764
 Net Income (TTM) (Millions $) -189
 Cash Flow (TTM) (Millions $) -65
 Capital Exp. (TTM) (Millions $) 32

Tandem Diabetes Care Inc
Tandem Diabetes Care Inc is a medical device company that is focused on developing and commercializing innovative products for individuals with diabetes. Based in San Diego, California, the company was founded in 2006 and went public in 2013.

Tandem Diabetes Care is primarily known for its insulin pump products, which are small, wearable devices that deliver insulin to people with diabetes. The company's flagship product is the t:slim X2 insulin pump, which was first launched in 2016. This pump uses a touchscreen interface and Bluetooth connectivity to provide patients with real-time data about their insulin delivery and glucose levels. The t:slim X2 also includes software updates that can be downloaded remotely, allowing patients to keep their device up-to-date with the latest features and improvements.

Tandem Diabetes Care has invested heavily in research and development, with a focus on creating products that are easier to use, more accurate, and more effective. The company has also made efforts to improve customer support and education, with a dedicated team of clinical specialists available to help patients learn how to use their devices and manage their diabetes.

In addition to its insulin pump products, Tandem Diabetes Care also offers a range of accessories and supplies, including infusion sets, cartridges, and other items that are needed to use the pump. The company's products are sold in the United States and internationally, with a network of distributors and other partners around the world.

Overall, Tandem Diabetes Care is a leading player in the diabetes care market, with a focus on innovation and customer satisfaction. As the prevalence of diabetes continues to grow globally, the company is well-positioned to serve the needs of patients and healthcare providers, and to continue developing new and improved products in the years ahead.


   Company Address: 12400 High Bluff Drive San Diego 92130 CA
   Company Phone Number: 366-6900   Stock Exchange / Ticker: NASDAQ TNDM
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Financing Agreement

Tandem Diabetes Care Prices Upsized Private Placement of $2750 Million of Convertible Senior Notes Due 2029; Quick Ratio Falls in Q4 2023

Published Wed, Mar 6 2024 5:46 AM UTC

Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029; Quick Ratio Falls in Q4 2023
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, has announced the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 in a private placement. This offering w...

Stock Transactions

Tandem Diabetes Care Proposes Private Placement of Convertible Notes to Fuel Growth and Innovation

Published Mon, Mar 4 2024 9:05 PM UTC

Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
San Diego-based Tandem Diabetes Care, Inc. (NASDAQ: TNDM) recently made public its intention to offer $250.0 million aggregate principal amount of Convertible Senior Notes due 2029 in a private placement to qualified institutional buyers. The offering is subject to market conditions and other ...

Product Service News

Transforming Diabetes Management: Tandem Diabetes and Abbott Unite to Revolutionize Insulin Delivery and Monitoring Technology

Published Mon, Jan 8 2024 1:00 PM UTC

In a groundbreaking collaboration, Tandem Diabetes Care, Inc., and Abbott have joined forces to integrate their cutting-edge technologies, marking significant advancements in insulin delivery and continuous glucose monitoring for individuals with diabetes. The recent integration of Tandem's t:slim X2 insulin pump with Control-IQ technology and Abbott's latest continuous gluc...

Tandem Diabetes Care Inc

Q2 2023 Report: Tandem Diabetes Care Inc Sales Dips, Encounters Major Revenue Slump



Tandem Diabetes Care Inc, a leading company in the Medical Equipment & Supplies industry, experienced a challenging second quarter of the fiscal year 2023. Weakening orders led to a deficit in the April to June 30 span. This article aims to analyze the financial results and provide insights into the company's performance during this period.
1. Revenue Decline and Earnings Per Share Comparison:
During the Q2 of 2023, Tandem Diabetes Care Inc's revenue decreased by -2.261%, amounting to $195.74 million. In terms of earnings per share (EPS), the company reported a shortfall of $-0.55 per share, a significant decline compared to $-0.24 per share in the corresponding period the previous year.

Tandem Diabetes Care Inc

Tandem Diabetes Care Inc Faces Revenue Dip of 3.709% in Q1 2023, But Industry Peers Fare Even Worse

Tandem Diabetes Care Inc, a medical equipment and supplies company, has just released its financial results for the 12 months ending in the first quarter of 2023. The report shows a cumulative net loss of $-204 million, resulting in a negative return on equity (ROE) of -49.39%. The ROE ranked Tandem Diabetes Care Inc at number 2974 out of the total companies recorded, which is a deterioration from the last quarter's ranking of 0.
While Tandem Diabetes Care Inc's loss is significant, it is not alone in the medical equipment and supplies industry. The report shows that 76 other companies in the industry recorded higher ROEs compared to Tandem Diabetes Care Inc's -49.39%.






 

Tandem Diabetes Care Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Tandem Diabetes Care Inc does not provide revenue guidance.

Earnings Outlook
Tandem Diabetes Care Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com